Clinical Evidence

Management of Sensitive Skin Syndrome

Palmitoyl Tetrapeptide-10 has shown efficacy in managing sensitive skin syndrome (SSS). A study demonstrated that a dermo-cosmetic product containing this peptide significantly reduced skin microcirculation increase and improved hydration after exposure to physical and chemical stressors. The product also alleviated unpleasant symptoms associated with SSS. For more details, see Management of triggering factor effects in sensitive skin syndrome with a dermo-cosmetic product.

Efficacy in Hyperpigmentation

In another study, Palmitoyl Tetrapeptide-10 was part of a skincare regimen that effectively reduced facial hyperpigmentation. Subjects reported significant improvements in skin tone and texture over 12 weeks, indicating its potential in addressing hyperpigmentation concerns. For further information, refer to An Open-Label Study Assessing the Efficacy and Tolerability of a Skincare Regimen in Subjects of Different Ethnicities with Moderate-to-Severe Hyperpigmentation.